Human medicines European public assessment report EPAR Kromeya adalimumab Arthritis RheumatoidArthritis Juvenile RheumatoidPsoriasisArthritis PsoriaticSpondylitis AnkylosingUveitisColitis UlcerativeCrohn Disease Date of authorisation 02

Human medicines European public assessment report EPAR Kromeya adalimumab Arthritis RheumatoidArthritis Juvenile RheumatoidPsoriasisArthritis PsoriaticSpondylitis AnkylosingUveitisColitis UlcerativeCrohn Disease Date of authorisation 02042019 Status Author...